Tata India Pharma & Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.37% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
3 - Minimum Investment₹5000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹1456 Cr
- Created on1 Dec 2015
Fund Ranking
#12
/ 15 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month15.7%
- 1 Year9.1%
- 3 Year (CAGR)20.7%
- All Time (CAGR)12.1%
Category Return
- 6 Month21.5%
- 1 Year13.1%
- 3 Year (CAGR)22.0%
- All Time (CAGR)-
Asset Allocation
- Equity97.4%
- Other2.6%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise4.61%
- Bayer CropScience3.20%
- Cipla4.77%
- Dr. Reddy's Laboratories4.26%
- FDC2.34%
Fund Information
- Expense Ratio2.28%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.88 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 16.74 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -3.04 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.99